Male Fertility Startup Inheritance scores $ 25 million in a Series B funding round led by Bain Capital Ventures.
Other investors participating in the raise include FirstMark Capital, Section 32 and TQ Ventures and Valor Equity Partners.
Legacy says the latest round brings its total increase to $ 45 million, an over-the-top building The $ 10 million Series A was announced last year and has $ 3.5 million in funding since early 2020.
What does this mean?
The Male Fertility Startup offers in-house sperm testing kits, semen analysis and cryopreservation. Users can order a test online and have it delivered to their home, where they collect a sample and schedule a pickup for analysis.
Examines inheritance samples and provides a report with lifestyle recommendations. Clients can set up telehealth appointments with doctors to discuss results and next steps.
CEO and founder Khaled Kateili said in a statement, “Bringing life to this world is one of the greatest joys of human life, but family planning can be daunting – and sometimes feel hopeless.” “Our goal is to address the issues of pain, humanize the experience rather than the clinical one, and help everyone build the family of their choice whenever they want.”
What is it for?
With Series B, Legacy plans to double the number of its employees and expand its offerings beyond testing, conservation and fertility assistance.
It will also launch a new venture called Legacy Labs. The company says that physical labs will provide services on the same day, at home to those who are planning surgery or treatment that may affect fertility and need to store sperm more quickly than cancer patients.
Snapshots of the market
Fertility And reproductive services are a growing market, although many offers focus on female fertility. More employers including fertility care as an advantage for their employees.
Another player increasing focus on fertility space is direct-to-consumer virtual care company Rowe, which announced in March that it was Acquired male fertility startup Dadi. About a year ago, Rowe acquired another fertility and reproductive health-centric company, Modern Fertility.
Hybrid Fertility Company Kindbody in February Vios Fertility Institute, a network of fertility clinics, has announced plans to acquire. Meanwhile, Prove, another fertility experimental startup, announced that it had raised $ 9.7 million in funding for the series in December.